Beruflich Dokumente
Kultur Dokumente
Case Presentation
I.
Identity
Name
Age
Gender
Tribe
Occupation
Address
In hospital since
II.
-
: NA
: 13 years old
: Women
: Javenese
:: Kedawung
: Mei 19th 2015
Anamnesis
Main Grievance
Additional Grievance
III.
A girl with her mother came to the Arjawinangun hospital because she felt unwell in
her stomach. There is a lump in the abdomen since 2 months ago. The patient also
feel the pain at abdomen. The patient feels nauseous. The stool was black indicated
that there was blood in her stool. There was palpable mass in her abdomen. And She
had not historical of hipertension.
IV.
Hipertension (-)
V.
Hipertension (-)
VI.
Physical Examination
General Status
Present Status
General Condition
Awareness
Blood Pressure
Pulse
Breathing
Temperature
: Moderate
: Composmantis
: 110/70
: 84 x/minute
: 20 x/minute
: 37,5 C
Head
1
: Normal, Simetrical
: Black Colour, No hair fall
: Anemic Conjungtival -/-, Icteric Schlera -/-, Light Refleks (+), Isocor
Ear
Nose
Mouth
Neck
Enlargement lymph nodes (-)
Trachea in the middle
No mass
Thoraks
Lungs - pulmonary
Inspection
: The chest shape is symmetrical both of left and right
Palpation
: Fremitus tactile and vocal symmetrical right and left,
crepitus (-), tenderness (-), rebound tenderness (-)
: Sound of resonant in both lung fields
: Sound of vesicular and bronchial the entire lung field, ronkhi -/-,
Percussion
Auscultation
wheezing -/-
Abdomen
Inspection
Palpation
Percussion
Auscultation
Extremity
Upper
Lower
Genitalia
: Lump in abdomen
: Tenderness (-), rebound tenderness (-)
: There was a deaf/somber in abdomen
: Bowel (+)
: Muscle Tone : normal
Movement : aktif / aktif
Mass
:-/Strenght
: 5/5
Edema
:-/: Muscle Tone : normal
Movement : aktif / aktif
Mass
:-/Strenght
: 5/5
Edema
:-/: No abnormalities
Laboratory Examination
Routine Blood
2
: 7790/mm3
: 8,8 gr/dL
: 253.000/mm3
: 25,1 %
Diagnosis
GIST
Differential Diagnosis
Two main differential diagnosis:
1. True gastric leimyoma or leimyosarkoma
2. Schwannoma
General differential diagnostic features of GIST reactive antibodies:
CD117 stains very few other spindled lesions but stains many carcinomas and
melanomas
CD34 stains many spindled lesions but stains almost no carcinomas or
melanomas
DOG1 stains very few spindled lesions or melanomas or carcinomas
Spindled, bland GIST DDx
Leiomyoma
Schwannoma
Fibromatosis
Sclerosing mesenteritis
Inflammatory fibroid polyp
Gastric plexiform fibromyxoma
Solitary fibrous tumor
Inflammatory myofibroblastic tumor
Endometrial stromal sarcoma
Calcifying fibrous pseudotumor
Spindled, malignant GIST DDx
Leiomyosarcoma
Malignant fibrous histiocytoma
Dedifferentiated liposarcoma
Epithelioid GIST
Poorly differentiated carcinoma
Melanoma/clear cell sarcoma
Glomus tumor
Gangliocytic paraganglioma
GI endocrine carcinoma
Extramedullary myeloid tumor
GI mucosal benign epithelioid nerve sheath tumo
Management
Operative
: Laparotomy, Omentectomy, Drainase
Prognosis
Quo ad vitam
: Ad bonam
3
: Dubia ad bonam
: Ad Bonam
Literature Review
The stomach is a sac-like organ that holds food and helps the digestive process by
secreting gastric juice. The food and gastric juices are mixed into a thick fluid
called chyme that is then emptied into the small intestine. The small intestine
continues breaking down the food and absorbs most of the nutrients into the
bloodstream. This is the longest section of the GI tract, measuring more than 20 feet.
The small intestine joins the large intestine, the first part of which is the colon, a
muscular tube about 5 feet long. The colon absorbs water and mineral nutrients from
the remaining food matter. The waste left after this process goes into the rectum as
stool (feces), where it is stored until it passes out of the body through the anus.
Anatomy
Stomach
4
Etiology
The exact cause of GIST is unknown. However, 95% of patients with GIST have a
protein called Kit (CD 117) that has become abnormal, which then causes normal
cells to grow faster and become cancerous.
Pathophysiology
GISTs can develop anywhere along the GI tract from the esophagus to the rectum;
however, stomach (60%) and small intestine (30%) are the most common locations
for GIST. Only 10% of GISTs are found in the esophagus, mesentery, omentum, colon
or rectum. Up to 30% of GISTs exhibit high-risk (malignant) behavior such as
metastasis and infiltration[8,9,13,14]. The metastatic pattern is predominantly intraabdominal, with spread throughout the peritoneal cavity and to the liver. Lymph nodal
invasion is uncommon. GISTs with indolent (low-risk) behavior are typically found as
small submucosal lesions. True smooth muscle tumors/leiomyomas also occur
throughout the GI tract but are now thought to be rare in comparison to GISTs, except
in the esophagus where they are more common
Symptoms and Signs
Some patients have no symptoms and their tumors are found accidentally. For
example, some tumors may be found when having testing or surgery for another
reason. However, some people may experience symptoms such as abdominal pain
and/or bloating, bleeding from the bowel, decreased appetite, and/or tiredness.
Only 70% of the patients with GIST are symptomatic. While 20% are asymptomatic
and the tumors are detected incidentally, 10% of the lesions are detected only at
autopsy. Symptoms and signs are not disease specific, they are related more to the site
of the tumor[6,7,16]. Bleeding (30%-40%) comprises the most common symptom
after WJGO|www.wjgnet.com 104 June 15, 2013|Volume 5|Issue 6| vague abdominal
discomfort (60%-70%). Bleeding is attributed to the erosion into the GIT lumen.
Bleeding occurring into the peritoneal cavity due to a ruptured GIST can lead to acute
abdominal pain presenting as a surgical emergency.
Bleeding into the GI tract lumen, causing hematemesis, melena or anemia, is usually
more chronic on presentation. Most of the patients present with vague symptoms,
such as nausea, vomiting, abdominal discomfort, weight loss or early satiety.
Symptoms are usually site specific. These include dysphagia in the esophagus, biliary
8
Diagnosis
No laboratory test can specifically confirm or rule out the presence of a GIST. The
following tests are generally ordered in the workup of patients who present with
nonspecific abdominal symptoms; abdominal pain; or complications of a GIST-like
hemorrhage, obstruction, or perforation:
Coagulation profile
Serum albumin
Imaging studies
Plain abdominal radiography:
Nonspecific
Can usually detect GISTs that have grown to a size sufficient to produce
symptoms
The overlying mucosa typically has a smooth contour unless ulceration has
developed
Can also be used to detect the presence of multiple tumors and of metastatic spread.
CT characteristics of small GISTs (< 5 cm) are as follows :
Sharply demarcated
Homogeneous density
Irregular shape
Heterogeneous density
Irregular margins
Heterogeneous densities
Indistinct margins
Heterogeneous enhancement
10
Like CT scanning, MRI can depict tumors and yield information about
surrounding structures
Can also be used to detect the presence of multiple tumors and metastases
Less well studied than CT for diagnosing GISTs, but appears equally sensitive
Endoscopy:
Obtaining a repeat biopsy in the same site as a prior biopsy may increase the
diagnostic yield
Complementary with CT
11
Heterogeneous echogenicity
EUS features that may help differentiate gastric GISTs from leiomyomas are as
follows:
Inhomogenicity
Hyperechogenic spots
A marginal halo
Management
Surgery is the definitive therapy for patients with GISTs, as follows:
Radical and complete surgical extirpation offers the only chance for cure
Other tyrosine kinase inhibitors are used when imatinib is not tolerated or is not
effective are as follows:
Complication
GIST can complicate unusual locations such as colonic interposition and should be
kept in the differential diagnosis of such unusual presentations.
Prognosis
GIST can transform into malignant on 10 30 % cases. The manifestation of
malignant can be high selularity, local invansion, distant metastases, that normally on
liver and peritoneum. The metastases rarely happens on regional lymph node, lungs,
or bones.
Prognosis becomes worse if there is rupture on tumor, location in distal part, high
selularity, necrosis on tumor, an invansion or other organs metastases and c-kit gen
mutation.
13
REFFERENCE
American Cancer Society. 2014. Gastrointestinal Stromal Tumor (GIST). Retrieved
from
http://www.cancer.org/acs/groups/cid/documents/webcontent/003103pdf.pdf
Lumongga F. 2008. Gastro Intestinal Stromal Tumor. Departemen Patologi Anatomi
Universitas Sumatera Utara : Medan
Rammohan A., Sathyanesan J., Rajendran K., Pitchaimuthu A., Perumal S., Srinivasan
UP, Ramasamy R., Palaniappan R., Govindan M. A gist of gastrointestinal
stromal tumors: A review. World J Gastrointest Oncol, 5(6), 102-112
Robbins & Cotran. 2009. Dasar Patologis Penyakit edisi 7. EGC : Jakarta
Wengert A., Andybee, Atkin A., Angieatkin, Brentwaldrop, Lenford B., dkk. 2010.
Human Physiology/The gastrointestinal system.
14